Literature DB >> 10639453

Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.

D L Goldman1, S C Lee, A J Mednick, L Montella, A Casadevall.   

Abstract

Fungal pathogens are notorious for causing chronic and latent infections, but the mechanism by which they evade the immune response is poorly understood. A major limitation in the study of chronic fungal infection has been the lack of suitable animal models where the infection is controlled and yet persists. Pulmonary Cryptococcus neoformans infection in rats results in a diffuse pneumonitis that resolves without dissemination or scarring except for the persistence of interstitial and subpleural granulomas that harbor viable cryptococci inside macrophages and epithelioid cells. Infected rats are asymptomatic but remain infected for as long as 18 months after inoculation with C. neoformans. Containment of infection is associated with granuloma formation that can be partially abrogated by glucocorticoid administration. Using this model, we identified several features associated with persistent infection in the rat lung, including (i) localization of C. neoformans to discrete, well-organized granulomas; (ii) intracellular persistence of C. neoformans within macrophages and epithelioid cells; (iii) reduced inducible nitric oxide synthase expression by granulomas harboring C. neoformans; and (iv) reduced antibody responses to cryptococcal polysaccharide. The results show that maintenance of persistent infection is associated with downregulation of both cellular and humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639453      PMCID: PMC97212          DOI: 10.1128/IAI.68.2.832-838.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  The pulmonary lesions in cryptococcosis with special reference to subpleural nodules.

Authors:  R K HAUGEN; R D BAKER
Journal:  Am J Clin Pathol       Date:  1954-12       Impact factor: 2.493

2.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Toxicology of sulphonamide-trimethoprim combinations.

Authors:  V Udall
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

4.  Primary pulmonary cryptococcosis.

Authors:  G D Campbell
Journal:  Am Rev Respir Dis       Date:  1966-08

5.  Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

Authors:  M Feldmesser; A Casadevall
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

6.  A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans.

Authors:  J A Lovchik; C R Lyons; M F Lipscomb
Journal:  Am J Respir Cell Mol Biol       Date:  1995-07       Impact factor: 6.914

7.  Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas.

Authors:  D Goldman; Y Cho; M Zhao; A Casadevall; S C Lee
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents.

Authors:  D L Goldman; B C Fries; S P Franzot; L Montella; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Pronounced enhancement of .NO-dependent antimicrobial action by an .NO-oxidizing agent, imidazolineoxyl N-oxide.

Authors:  K Yoshida; T Akaike; T Doi; K Sato; S Ijiri; M Suga; M Ando; H Maeda
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.

Authors:  M Deshaw; L A Pirofski
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

View more
  59 in total

Review 1.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

2.  Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.

Authors:  Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.

Authors:  Kerstin Voelz; David A Lammas; Robin C May
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

4.  Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii.

Authors:  Keigo Ueno; Yuki Kinjo; Yoichiro Okubo; Kyoko Aki; Makoto Urai; Yukihiro Kaneko; Kiminori Shimizu; Dan-Ni Wang; Akiko Okawara; Takuya Nara; Kayo Ohkouchi; Yuki Mizuguchi; Susumu Kawamoto; Katsuhiko Kamei; Hideaki Ohno; Yoshihito Niki; Kazutoshi Shibuya; Yoshitsugu Miyazaki
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

5.  Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans.

Authors:  Carolina Coelho; Ana Camila Oliveira Souza; Lorena da Silveira Derengowski; Carlos de Leon-Rodriguez; Bo Wang; Rosiris Leon-Rivera; Anamelia Lorenzetti Bocca; Teresa Gonçalves; Arturo Casadevall
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

6.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

7.  Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?

Authors:  Joseph N Jarvis; Thomas S Harrison; Elizabeth L Corbett; Robin Wood; Stephen D Lawn
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

8.  Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.

Authors:  D C Saha; D L Goldman; X Shao; A Casadevall; S Husain; A P Limaye; M Lyon; J Somani; K Pursell; T L Pruett; N Singh
Journal:  Clin Vaccine Immunol       Date:  2007-10-24

9.  Cryptococcal cell morphology affects host cell interactions and pathogenicity.

Authors:  Laura H Okagaki; Anna K Strain; Judith N Nielsen; Caroline Charlier; Nicholas J Baltes; Fabrice Chrétien; Joseph Heitman; Françoise Dromer; Kirsten Nielsen
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

Review 10.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.